Lion Point Capital »

Syndax Pharmaceuticals shares owned by Lion Point Capital

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $746k 35k 21.61
2023-09-30 $501k 35k 14.52
2023-06-30 $722k 35k 20.93

More positions owned by Lion Point Capital

Semtech Corporation (SMTC)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Marinus Pharmaceuticals Com New (MRNS)
Ardelyx (ARDX)
Milestone Pharmaceuticals (MIST)
Harpoon Therapeutics Com New
Burgerfi International (BFI)
Kiniksa Pharmaceuticals Com Cl A (KNSA)
Insmed Com Par $.01 (INSM)
Battalion Oil Corp (BATL)
Cymabay Therapeutics
Fennec Pharmaceuticals (FENC)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Enphys Acquisition Corp Cl A Ord Shs (NFYS)
Syndax Pharmaceuticals (SNDX)

View all positions for Lion Point Capital

Top funds holding Syndax Pharmaceuticals

Wellington Management Company
Kynam Capital Management
Vanguard Group
venBio Select Advisor
Avidity Partners Management
Point72 Asset Management
Marshall Wace
BVF
OrbiMed Advisors
Franklin Resources
Goldman Sachs Group
Cormorant Asset Management
Bank of America Corporation
Aisling Capital Management
Candriam Luxembourg S.C.A.

View all funds holding Syndax Pharmaceuticals